GRAPHene enhanced pre-CAST concrete (GRAPHcast)
GRAPHene enhanced pre-CAST concrete (GRAPHcast)
批准号:
10081858
负责人:
金额:
$95.58万
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
预制混凝土比现场混凝土浇筑更经济实惠,可控,安装更快,符合英国政府促进场外制造/模块化建设的雄心。[1\]然而,今天的预制混凝土混合物带来了许多挑战:1\。水泥(混凝土的粘合剂)的生产是高碳密集型的(860 kgCO2e/吨)[2]。达到设计强度所需的水泥含量使预制混凝土具有较高的碳足迹(256 - 329kgCO2e/cu. m),尽管使用了水泥增强剂。水泥替代品延迟固化/强度发展(16小时脱模,14天安全运输),限制了生产率,并有在处理/储存期间损坏的风险。钢筋增强了早期强度,但增加了产品成本和碳排放。Nationwide-Engineering-Research-and-Development-Ltd(NERD)的石墨烯增强混凝土(GEC)专利外加剂CONCRETENE此前已开发用于预拌混凝土领域,石墨烯的增强效果可以减少水泥含量,或与传统普通硅酸盐水泥(OPC)相比减少混凝土体积。或增强材料混合物(例如CEM-III)。这些材料节省带来了显著的碳足迹减少(减少高达30%)。除了脱碳,混凝土还能加速强度发展/缩短固化时间(例如,在I-UK:99366,220吨混凝土板在24小时内达到28天的设计强度)。因此,CONCRETENE非常适合解决预制行业的主要挑战,但首先需要重新配制,以满足预制件与预拌件更复杂的化学和生产需求。GRAPHCAST项目是CONCRETENE开发商NERD和Roger-Bullivant-Ltd(RBL)之间的合作,Roger-Bullivant-Ltd(RBL)是国际Vinci集团的一部分,该集团合并了Soletanche-Bachy,建筑基础领域的世界领导者,在60个国家开展业务。除了NERD迭代的CONCRETENE重新制定外,RBL的测试,放大和现场试验将评估住宅建筑和低层结构的预制桩和梁的性能。最后,通过在现场施工现场验证性能,GRAPHcast将为混凝土的快速商业化铺平道路。虽然预制混凝土的市场比预拌混凝土小(因此对私人投资者的吸引力较小),但在短期内更容易开发,因为销售可以利用RBL完善的销售网络,而不是依赖NERD直接向个别公司销售。[1\]建设-剧本:https://www.gov.uk/government/publications/the-construction-playbook\[2\] ICE:https://www.ice.org.uk/media/200i0yqd/2022-04-26-low-carbon-concrete-routemap-final\_rev.pdf
英文摘要
Pre-cast concrete is more affordable, controllable, quicker-to-install than onsite concrete-casting and aligns with UK Govt ambition to promote off-site manufacturing/modular construction.\[1\]However, today's pre-cast concrete mixes pose numerous challenges:1\. The production of cement (concrete's binding agent) is highly-carbon-intensive (860kgCO2e/tonne)\[2\].2\. The cement content required to reach design strength gives pre-cast concrete a high carbon footprint (256-329kgCO2e/cu.m), despite using cement replacements.3\. Cement replacements retard curing/strength-development (16-hour-demoulding, 14-day safe-transport), limiting productivity and risking damage during handling/storage.4\. Steel reinforcement enhances early-age-strength but increases product-cost and embodied-carbon.Nationwide-Engineering-Research-and-Development-Ltd(NERD)'s patented Graphene-Enhanced-Concrete(GEC) admixture, CONCRETENE, has been previously developed for the ready-mixed concrete sector, where the strength-enhancing effect of graphene enables reduced cement-content, or reduced concrete-volumes compared to traditional Ordinary-Portland-Cement(OPC), or replacement-material blends (e.g.CEM-III). These material-savings deliver a significantly reduced carbon-footprint (up to 30% reduction).In addition to decarbonisation, CONCRETENE accelerates strength-development/reduces curing time (e.g. 220-Tonne CONCRETENE slab reached 28-day design strength in just 24-hours in I-UK:99366). CONCRETENE is therefore ideally suited to address the major precast sector challenges, but first needs to be reformulated to meet the more complex-chemistries and production-demands of precast vs ready-mixed.The GRAPHcast project is a collaboration between CONCRETENE developers, NERD, and Roger-Bullivant-Ltd(RBL), part of the international Vinci-Group that incorporates Soletanche-Bachy, world-leader in building-foundations, with operations in 60 countries.Alongside iterative CONCRETENE reformulation by NERD, testing, scale-up, and site-trials by RBL will assess performance in precast piles and beams for residential-buildings and low-rise structures. Finally, by validating performance on a live-construction site, GRAPHcast will pave the way for rapid commercialisation of CONCRETENE. Although precast is a smaller market than ready-mixed concrete (and therefore less attractive to private-investors), it is easier to exploit in the short-term, since sales can leverage the well-established sales-network of RBL, in contrast to relying on NERD making direct-sales to individual companies.\[1\]Construction-Playbook:https://www.gov.uk/government/publications/the-construction-playbook\[2\] ICE: https://www.ice.org.uk/media/200i0yqd/2022-04-26-low-carbon-concrete-routemap-final\_rev.pdf
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
-
批准号:82371251
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:肖勤
-
依托单位: